TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DTIL

Precision BioSciences Inc

Healthcare · Biotechnology

7.20$ +10.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Precision BioSciences Inc (DTIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 126 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DTIL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
164 160 185 166 153 136 124 109 94 154 144 126
146 136 161 144 111 95 82 70 52 119 109 92
122 117 138 124 99 86 77 62 45 111 99 86
122 117 138 124 101 86 77 62 45 116 101 88
15 13 13 14 1.5 1.7 0.0 5.7 0.0 0.0 4.0 0.0
0.6 0.6
1.0 0.4 0.4 0.4 0.4 0.6 0.6 0.6 1.0 1.2 1.1 1.1
135 141 148 91 88 80 75 75 77 62 68 81
51 50 33 33 12 15 12 14 15 8.9 7.8 7.1
24 24 24 24 1.3 1.3 1.4 1.4 1.5 1.5 1.6 1.6
0.5 3.0 1.1 1.1 1.0 1.3 0.9 1.1 1.3 0.3 0.9 0.8
22 22 22 22 22 22 22
29 19 37 75 65 56 49 34 17 92 76 45
-473 -490 -481 -448 -465 -482 -503 -527 -548 -528 -547 -579
3.8 4.5 5.1 7.0 7.3 6.9 9.0 11 12 19 25 26

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?